Skip to content

Effect of Height Based vs Conventional Dose of Spinal Anesthesia in Lower Limb Surgeries

Comparison of Incidence of Hemodynamics and Block Characteristics Between Height Based Versus Conventional Fixed Dose Spinal Anesthesia in Lower Limb Surgeries: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07751835
Enrollment
104
Registered
2026-08-07
Start date
2026-08-20
Completion date
2027-08-01
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Surgeries

Brief summary

This study aim is to compare height based dose of spinal anesthesia vs conventional dose. Hypothesis is height based dose has less hemodynamics changes compared to conventional dosing.

Detailed description

This is a prospective, randomized, double blinded, controlled trial with minimum 6 months of data collection. Patients will be divided into two groups randomly. Group H and C each having 52 patients. Groups H will be given spinal anesthesia dose according to their height by pre determined dosing algorithm. Group C will be given a fixed dose of Hyperbaric Bupivacaine 0.5% 12.5mg (2.5ml) without adjusting it according to their height. Pateint's blood pressure and Heart rate along with sensory effect will be recorded 5,10 and 15 minutes later after spinal anesthesia. I will be recording any episode of bradycardia and hypotension and intervention needed to treat it in both the groups

Interventions

DRUGHeight based dose of hyperbaric bupivacaine 0.5%

Height based vs Conventional dosing of spinal anesthesia in lower limb surgeries

Sponsors

Liaquat National Hospital & Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* both genders. 18-65 years age ASA physical status I and II

Exclusion criteria

* ASA III and IV Refusal of patient Height less than 150 cm Known allergy to study drug

Design outcomes

Primary

MeasureTime frame
Hypotension and Bradycardia6 months
Icidence of hypotension and bradycardia6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026